• Chapter Meetings
  • Grand Rounds
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease
  • Oncology
Click here to participate on 5/11: https://us06web.zoom.us/j/87656374015
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm
  • Oncology
Click here to participate on 5/12: https://us06web.zoom.us/j/83171648955
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Chapter Meetings
  • Grand Rounds
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease
  • Oncology
To register in advance, click here: https://us06web.zoom.us/webinar/register/WN_8qH0_AAdQ
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Optimizing Outcomes for Adults with Spinal Muscular Atrophy: Patient-Centric Strategies for the Interprofessional Treatment Team
  • Other
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Collaborative Strategies for the Interprofessional Team: Advancing Clinical Outcomes in CLL Using Novel Agents
  • Oncology
To register in advance click here: https://us06web.zoom.us/we
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease
  • Oncology
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Live Online
Immunotherapy in Upper GI Cancers: A Multidisciplinary Discussion of the Data and Real-World Barriers Faced in Practice
  • Gastrointestinal
  • Oncology
This 60-minute program will explore real-world applications of the data to practice, with a diverse panel crossing a range of disciplines offering unique perspectives on the immunotherapy terrain i
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm
  • Oncology
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Optimizing Outcomes for Adults with Spinal Muscular Atrophy: Patient-Centric Strategies for the Interprofessional Treatment Team
  • Other
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation
  • Grand Rounds
Collaborative Strategies for the Interprofessional Team: Advancing Clinical Outcomes in CLL Using Novel Agents
  • Oncology
To register in advance click here: https://us06web.zoom.us/webinar/register/WN_dYNRNh4CTgWAkxe4BtCzaQ
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 IPCE
  • 1.00 Participation

Pages